Therapeutic research in untreated acute promyelocytic leukemia
Open Access
- 21 April 2005
- journal article
- editorial
- Published by Springer Nature in Leukemia
- Vol. 19 (6) , 913-915
- https://doi.org/10.1038/sj.leu.2403767
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemiaLeukemia, 2005
- All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemiaBlood, 2004
- Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experienceLeukemia, 2004
- Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemiaBlood, 2004
- All-trans retinoic acid/As 2 O 3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemiaProceedings of the National Academy of Sciences, 2004
- Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA groupBlood, 2003
- Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-upBlood, 2002
- Experience with gemtuzumab ozogamycin (“mylotarg”) and all-trans retinoic acid in untreated acute promyelocytic leukemiaBlood, 2002
- Therapy of Molecular Relapse in Acute Promyelocytic LeukemiaBlood, 1999
- A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic LeukemiaBlood, 1999